Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “ras”

843 pharma patents match "ras" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 843
Index total 30,257
Page 20 / 36

Quick answer

This filtered view shows 843 pharmaceutical patents matching "ras" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

843 results for “ras” · 30,257 patents in full index Clear search

  1. US 9067989

    Eotaxin-2 (CCL24) inhibitors in inflammatory, autoimmune, and cardiovascular disorders

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Jun 30, 2015 · Expires Jun 25, 2035

    granted

  2. US 9045550

    Peptides and compositions for prevention of cell adhesion and methods of using same

    Tel Hashomer Medical Research, Infrastructure and Services Ltd, the Technology Transfer Company of Chaim · Granted Jun 2, 2015 · Expires May 28, 2035

    granted

  3. US 9044381

    Method for delivering drugs to the brain

    Board of Regents of the University of Nebraska by and behalf of the University of Nebraska Medical Center · Granted Jun 2, 2015 · Expires May 28, 2035

    granted

  4. US 9040542

    Solid forms of gyrase inhibitor (R)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl)pryimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1H-benzimidazol-2-yl]urea

    Vertex Pharmaceuticals Incorporated · Granted May 26, 2015 · Expires May 21, 2035

    granted

  5. US 9029318

    Peptides and compositions for prevention of cell adhesion and methods of using same

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted May 12, 2015 · Expires May 7, 2035

    granted

  6. US 9023858

    Substituted pyrido[2,3-d]pyrimidines as delta-5-desaturase inhibitors

    Takeda Pharmaceutical Company Limited · Granted May 5, 2015 · Expires Apr 30, 2035

    granted

  7. US 9018201

    Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiency

    BIOMARIN PHARMACEUTICAL INC. · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  8. US 9012641

    Crystalline forms of Prasugrel salts

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  9. US 8999987

    Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)

    BIOMARIN PHARMACEUTICAL INC. · Granted Apr 7, 2015 · Expires Apr 2, 2035

    granted

  10. US 8986736

    Method for delivering particulate drugs to tissues

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted

  11. US 8980549

    MicroRNA patterns for the diagnosis, prognosis and treatment of melanoma

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Mar 17, 2015 · Expires Mar 12, 2035

    granted

  12. US 8980902

    Poly (ADP-ribose) polymerase (PARP) inhibitors

    Takeda Pharmaceutical Company Limited · Granted Mar 17, 2015 · Expires Mar 12, 2035

    granted

  13. US 8969359

    Gyrase and topoisomerase IV inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted

  14. US 8969292

    High affinity leptins and leptin antagonists

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted

  15. US 8969406

    Use of compound for inhibiting glutathione s-transferase omega 1 activity and method for synthesizing the same

    China Medical University · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted

  16. US 8961993

    Method of treating retinitis pigmentosa

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted

  17. US 8962685

    Creatine oral supplementation using creatine hydrochloride salt

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted

  18. US 8962561

    Compositions comprising PEDF and uses of same in the treatment and prevention of ovary-related syndromes

    The Fund for Medical Research, Development of Infrastructure and Health Services—Assaf HaRofeh Medical Center · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted

  19. US 8946455

    Semi-synthetic small molecules for the treatment parasitic disease

    The Regents of the University of California · Granted Feb 3, 2015 · Expires Jan 29, 2035

    granted

  20. US 8946300

    Use of rasagilline for the treatment of restless legs syndrome

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 3, 2015 · Expires Jan 29, 2035

    granted

  21. US 8946271

    Water soluble furoxan derivatives having antitumor activity

    HUMANITAS MIRASOLE S.P.A. · Granted Feb 3, 2015 · Expires Jan 29, 2035

    granted

  22. US 8937053

    Process for the preparation of prasugrel and several novel crystalline forms of prasugrel hydrochloride

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Jan 20, 2015 · Expires Jan 15, 2035

    granted

  23. US 8932588

    Treatment of cancer involving mutated KRAS or BRAF genes

    TEVA PHARMACEUTICALS AUSTRALIA PTY LTD · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted

  24. US 8932561

    Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent

    Lutonix, Inc. · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.